AutoeCTD™
eCTD submission packaging for jurisdictions like the FDA, EMA, and Health Canada — and any agency that accepts the format.
Drop a folder.
Get a valid sequence.
Upload your raw documents. Our classification engine assigns them to the
correct ICH M4 Module 1–5 sections, auto-fills the regional cover form,
computes MD5 checksums, and writes the eCTD XML backbone. You review.
We package — for whichever agency you're filing with.
- AI document classification into ICH M4 Module 1–5 sections
- Regional cover form auto-population (FDA Form 356h, Health Canada equivalents, more)
- eCTD v3.2.2 XML backbone with regional adapters
- MD5 integrity checksums for every leaf
- SharePoint package delivery
In pilot
Multi-jurisdiction · ICH M4
AutoeXML™
Regulatory XML automation — FDA SPL and Health Canada XML PM.
From Word draft
to gateway-ready XML.
Drop in a labeling document. AutoeXML extracts the sections, classifies
them against jurisdiction-specific code libraries (FDA SPL / Health Canada
SPM 2020), validates against official vocabularies, and emits schema-valid
XML — ready for ESG transmission.
- FDA SPL v3 + Health Canada SPM 2020 adapters
- Three-layer classification with LOINC and HPFB code libraries
- Live validation against official FDA and HC vocabularies
- OTC, REMS, establishment registration, drug listing
- e-signature workflow with append-only audit trail
In pilot
FDA SPL · HC SPM 2020
AutoeDEF™
Deficiency response intelligence.
Never write the same response twice.
AutoeDEF reads incoming agency correspondence, extracts each deficiency
point, and drafts a response grounded in your own historical submissions.
Track what was accepted, what was rejected, and benchmark your performance
by category and agency.
- Automated deficiency extraction from agency correspondence
- Vector search across your historical response library
- Grounded draft generation with source citation
- Outcome tracking — Accepted / Rejected / Partial
- Response effectiveness benchmarking
In pilot
Multi-agency
AutoeDOC™
Regulatory document authoring — Module 2 summaries, prescribing information, and submission-ready drafts.
Draft from source.
Not from a blank page.
AutoeDOC drafts the documents that go into a regulatory submission — Quality
Overall Summaries, Clinical and Nonclinical Overviews, prescribing information,
risk management plans — using your source data and prior-approved precedent.
Your senior writers review, refine, and approve. The blank-page problem disappears.
- Module 2 summary drafting from CMC, nonclinical, and clinical data
- Product Monograph and prescribing information generation
- Legacy PM conversion to the 2020 Master Template
- Source-grounded drafting with citation back to underlying study reports
- Append-only audit trail of every AI suggestion and human edit
In pilot
FDA · Health Canada · ICH M4
AutoeLABEL™
Branded and generic drug labeling — creation, updates, and reference-product alignment.
One label engine.
Brand and generic.
AutoeLABEL creates new drug labels and keeps generic labels aligned with the
Canadian Reference Product. When the brand updates a safety section, the generic
label updates with a drafted change for your team to review and submit. No more
manual diffing across hundreds of generic SKUs.
- Branded label authoring from prescribing information and CMC data
- Generic label maintenance with automatic CRP alignment
- Brand safety update detection across reference product sources
- Side-by-side diff for review and submission of label changes
- Bilingual handling for Health Canada English/French requirements
In active development
FDA · Health Canada
AutoeQA™
Quality lifecycle management — change controls, deviations, and CAPA workflows.
Quality events.
Connected to submissions.
AutoeQA handles change controls, deviation investigations, and CAPA workflows —
connected directly to the regulatory submission pipeline. When a manufacturing
change is approved, the downstream label and submission updates are drafted
automatically. Quality and Regulatory, finally talking to each other.
- Change control workflow with regulatory impact assessment
- Deviation and investigation case management
- CAPA tracking with effectiveness review
- Auto-trigger of downstream label and submission updates
- 21 CFR Part 11 audit trail across the quality lifecycle
On the roadmap
2026–2027